Earnings Per Share: The Building Block Nobody Checks
EPS is arithmetic, not magic. Take a company's net profit, subtract any preference dividends, and divide by the number of ordinary shares in issue. That is it.
AstraZeneca posted £7.2 billion in net profit in its most recent full year on roughly 1.5 billion shares — giving an EPS near £4.94. That £4.94 is the raw per-share earnings that fund everything else: the dividend, the buybacks, the R&D budget. When the share price is £139, the market is paying 28 times those earnings — the P/E ratio.
Barclays, by contrast, earned the equivalent of about £0.43 per share last year while trading at £4.28. A P/E of 9.9. The market is pricing Barclays at less than 10 times earnings while AstraZeneca commands nearly three times that multiple. Same index, same currency, vastly different expectations.
What actually moves EPS. Three things matter. First, profit growth — or shrinkage. If Barclays doubles earnings without issuing new shares, EPS doubles. Second, share buybacks. If a company buys back 10% of its shares, EPS rises 11% even if profits are flat. Third, dilution. If a company issues new shares to fund an acquisition or pay executive bonuses, EPS gets spread thinner across more shares.
Buybacks are the invisible EPS booster. Shell bought back roughly £10 billion of its own shares in 2025. That mechanically boosts EPS without the business selling a single additional barrel of oil. Whether that is smart capital allocation or short-term cosmetic management is the debate — but the EPS number does not distinguish between the two.
Companies report EPS figures in their annual reports filed with Companies House. For UK-listed firms, the FCA's Listing Rules require disclosure of basic and diluted EPS. Diluted EPS accounts for all potential new shares — options, convertibles, warrants — and is almost always the lower, more honest number. When a company trumpets its basic EPS growth but buries the diluted figure in note 37 of the annual report, that is not an accident.
Shell data page: see live fundamentals including EPS history.